Agilent Technologies, Inc. Files 10-Q for Period Ending January 31, 2024

TL;DR

<b>Agilent Technologies filed its Q1 2024 10-Q, detailing financial performance and balance sheet information as of January 31, 2024.</b>

AI Summary

AGILENT TECHNOLOGIES, INC. (A) filed a Quarterly Report (10-Q) with the SEC on March 5, 2024. Agilent Technologies reported financial results for the quarter ended January 31, 2024. The filing covers the period from November 1, 2023, to January 31, 2024. Key financial statement items such as common stock, additional paid-in capital, retained earnings, and accumulated other comprehensive income are detailed for various periods. The company's fiscal year ends on October 31. Agilent Technologies is classified under the SIC code 3826 for Laboratory Analytical Instruments.

Why It Matters

For investors and stakeholders tracking AGILENT TECHNOLOGIES, INC., this filing contains several important signals. This 10-Q provides investors with a detailed look at Agilent's financial health and operational performance during the first fiscal quarter of 2024, enabling informed investment decisions. Understanding the company's financial position, including its equity structure and changes in retained earnings, is crucial for assessing its stability and growth prospects.

Risk Assessment

Risk Level: low — AGILENT TECHNOLOGIES, INC. shows low risk based on this filing. The filing is a standard quarterly report (10-Q) and does not contain unusual or high-risk disclosures, indicating a routine update on the company's financial status.

Analyst Insight

Review the detailed balance sheet and income statement data within the 10-Q to assess trends in revenue, expenses, and profitability for the reported quarter.

Key Numbers

• 2024-01-31 — Quarter End Date (Period of report)
• 2024-03-05 — Filing Date (Date the report was filed)
• 1031 — Fiscal Year End (Company's fiscal year end)
• 3826 — SIC Code (Standard Industrial Classification)

Key Players & Entities

• AGILENT TECHNOLOGIES, INC. (company) — Filer name
• 2024-01-31 (date) — Period of report
• 2024-03-05 (date) — Filing date
• 3826 (industry_code) — Standard Industrial Classification
• 5301 STEVENS CREEK BLVD (address) — Business address
• SANTA CLARA (city) — Business address city
• CA (state) — Business address state
• 95051 (zip_code) — Business address zip

FAQ

Industry Context

Agilent Technologies operates in the laboratory analytical instruments industry, providing a range of products and services for life sciences, diagnostics, and applied chemical markets.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, requiring public companies to submit regular financial disclosures to the SEC.

What Investors Should Do

1. Analyze the detailed financial statements for the quarter ended January 31, 2024, comparing key metrics to prior periods.
2. Review the company's equity structure, including changes in common stock, additional paid-in capital, and retained earnings.
3. Note the company's fiscal year end of October 31 for future financial reporting context.

Key Dates

• 2024-01-31: Quarter End — End of the reporting period for the 10-Q filing.
• 2024-03-05: Filing Date — Date the 10-Q was officially submitted to the SEC.

Year-Over-Year Comparison

This filing is a standard quarterly report (10-Q) and does not inherently provide comparative data against a previous filing within this specific output, but it does reference data points from prior periods within its financial statements.

Key Financial Figures

• $0.01 — ange on which registered Common Stock, $0.01 par value A New York Stock Exchange I

Filing Documents

• a-20240131.htm (10-Q) — 1543KB
• a-01312024xex311.htm (EX-31.1) — 12KB
• a-01312024xex312.htm (EX-31.2) — 12KB
• a-01312024xex321.htm (EX-32.1) — 6KB
• a-01312024xex322.htm (EX-32.2) — 5KB
• 0001090872-24-000011.txt (&nbsp;) — 9904KB
• a-20240131.xsd (EX-101.SCH) — 53KB
• a-20240131_cal.xml (EX-101.CAL) — 60KB
• a-20240131_def.xml (EX-101.DEF) — 540KB
• a-20240131_lab.xml (EX-101.LAB) — 932KB
• a-20240131_pre.xml (EX-101.PRE) — 703KB
• a-20240131_htm.xml (XML) — 1565KB

Management's Discussion and Analysis of Financial Condition and Results of Operations

Management's Discussion and Analysis of Financial Condition and Results of Operations 31 Item 3.

Quantitative and Qualitative Disclosures About Market Risk

Quantitative and Qualitative Disclosures About Market Risk 44 Item 4.

Controls and Procedures

Controls and Procedures 44 Part II. Other Information 45 Item 1.

Legal Proceedings

Legal Proceedings 45 Item 1A.

Risk Factors

Risk Factors 45 Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 57 Item 5. Other Information 57 Item 6. Exhibits 58 Signature 59 2 Table of Contents

— FINANCIAL INFORMATION

PART I — FINANCIAL INFORMATION

CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

ITEM 1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED) AGILENT TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS (in millions, except per share amounts) (Unaudited) Three Months Ended January 31, 2024 2023 Net revenue: Products $ 1,209 $ 1,323 Services and other 449 433 Total net revenue 1,658 1,756 Costs and expenses: Cost of products 514 556 Cost of services and other 236 232 Total costs 750 788 Research and development 128 123 Selling, general and administrative 396 419 Total costs and expenses 1,274 1,330 Income from operations 384 426 Interest income 18 9 Interest expense ( 22 ) ( 25 ) Other income (expense), net 23 — Income before taxes 403 410 Provision for income taxes 55 58 Net income $ 348 $ 352 Net income per share: Basic $ 1.19 $ 1.19 Diluted $ 1.18 $ 1.19 Weighted average shares used in computing net income per share: Basic 293 296 Diluted 294 297 The accompanying notes are an integral part of these condensed consolidated financial statements. 3 Table of Contents AGILENT TECHNOLOGIES, INC. CONDENSED CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME (LOSS) (in millions) (Unaudited) Three Months Ended January 31, 2024 2023 Net income $ 348 $ 352 Other comprehensive income (loss): Unrealized loss on derivative instruments, net of tax benefit of $( 3 ) and $( 9 ) ( 7 ) ( 22 ) Amounts reclassified into earnings related to derivative instruments, net of tax benefit of $( 1 ) and $( 2 ) ( 2 ) ( 4 ) Foreign currency translation, net of tax expense (benefit) of $ 0 and $( 1 ) 21 91 Net defined benefit pension cost and post retirement plan costs: Change in actuarial net gain (loss), net of tax expense (benefit) of $( 1 ) and $ 0 ( 1 ) 2 Other comprehensive income 11 67 Total comprehensive income $ 359 $ 419 The accompanying notes are an integral part of these condensed consolidated financial statements. 4 Table of Contents AGILENT TECHNOLOGIES, INC. CONDENSED CONSOLID

View Full Filing

View this 10-Q filing on SEC EDGAR